Advanced in Eosinophilic Colitis

Dr. Philippe Begin

Allergy and Immunology
El Camino Health
2500 Grant Rd, 
Mountain View, CA 
Advanced in Eosinophilic Colitis
El Camino Health
2500 Grant Rd, 
Mountain View, CA 
OverviewInsuranceLocationsClinical Research

Overview

Philippe Begin is an Allergy and Immunologist in Mountain View, California. Dr. Begin is rated as an Advanced provider by MediFind in the treatment of Eosinophilic Colitis. His top areas of expertise are Food Allergy, Anaphylaxis, Asthma, and Eosinophilic Colitis.

His clinical research consists of co-authoring 154 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Eosinophilic Colitis.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

El Camino Health
2500 Grant Rd, Mountain View, CA 94040

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age.
A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age.
Enrollment Status: Completed
Publish Date: December 16, 2024
Intervention Type: Biological
Study Phase: Phase 3
A 15 Months, Double-Blind, Randomized Controlled Trial Comparing 20 Weeks of Two Dosages of Omalizumab to Placebo to Accelerate a Symptom-driven Oral Immunotherapy Schedule in Subjects Aged 6 to 25 Years With Multiple Food Allergies
A 15 Months, Double-Blind, Randomized Controlled Trial Comparing 20 Weeks of Two Dosages of Omalizumab to Placebo to Accelerate a Symptom-driven Oral Immunotherapy Schedule in Subjects Aged 6 to 25 Years With Multiple Food Allergies
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Biological, Other
Study Phase: Phase 2
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Safety Study of Viaskin Peanut to Treat Peanut Allergy
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

149 Total Publications

Publisher Correction: Immunoglobulin E (IgE)-mediated food allergy.
Publisher Correction: Immunoglobulin E (IgE)-mediated food allergy.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: June 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Begin's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile